Previous Close | 0.2150 |
Open | 0.1806 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.2150 - 0.2150 |
52 Week Range | 0.1700 - 0.3800 |
Volume | |
Avg. Volume | 3,165 |
Market Cap | 6.471M |
Beta (5Y Monthly) | 0.51 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings Date | May 06, 2024 - May 10, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the quarter ended December 31, 2023 was $11.5 million ...
HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023.Revenue for the quarter ended September 30, 2023 was $12.9 million ...
Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023.